Citation: L. Raez et al., ACQUIRED-IMMUNODEFICIENCY-SYNDROME (AIDS) RELATED PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA (PCNSL) IN A HISPANIC POPULATION, Blood, 90(10), 1997, pp. 3942-3942
Citation: L. Raez et al., PROGNOSTIC FACTORS FOR SURVIVAL IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME(AIDS) AND NON-AIDS RELATED PATIENTS WITH PRIMARY CENTRAL-NERVOUS-SYSTEM LYMPHOMA (PCNSL), Blood, 90(10), 1997, pp. 3943-3943
Authors:
KRAJEWSKA M
KRAJEWSKA S
YOUNG M
WELLER E
NEIMAN R
MEDERIOS J
GLICK J
VENKATRAJ U
GORDON L
CASSILETH P
REED JC
Citation: M. Krajewska et al., EXPRESSION OF APOPTOSIS-REGULATORY PROTEINS BCL-2, BAX AND CASPASE-3 IN NON-HODGKINS-LYMPHOMAS - AN ECOG STUDY (E6491), Blood, 90(10), 1997, pp. 328-328
Authors:
GORDON LI
ANDERSEN J
HABERMANN TM
WINTER JN
GLICK J
SCHILDER RJ
CASSILETH P
Citation: Li. Gordon et al., PHASE-I TRIAL OF DOSE-ESCALATION WITH GROWTH-FACTOR SUPPORT IN PATIENTS WITH PREVIOUSLY UNTREATED DIFFUSE AGGRESSIVE LYMPHOMAS - DETERMINATION OF THE MAXIMUM-TOLERATED DOSE OF PROMACE-CYTABOM, Journal of clinical oncology, 14(4), 1996, pp. 1275-1281
Authors:
SCHENKEIN DP
ROITMAN D
MILLER KB
MORELLI J
STADTMAUER E
PECORA AL
CASSILETH P
LAZARUS HM
Citation: Dp. Schenkein et al., A PHASE-II TRIAL OF FILGRASTIM (G-CSF) SUPPORTED HIGH-DOSE SEQUENTIALCHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL (PBSC) TRANSPLANTATION ASINITIAL THERAPY FOR HIGH-RISK NON-HODGKINS LYMPHOMA(NHL) - A MULTICENTER PILOT-STUDY, Blood, 88(10), 1996, pp. 462-462
Authors:
KITADA S
BULLRICH F
KRAJEWSKI S
ZAPATA J
ANDERSEN J
HINES J
CASSILETH P
CROCE CM
HEED JC
Citation: S. Kitada et al., BCL-2 FAMILY GENES, CPP32 PROTEASE, 13Q14 DELETIONS, AND IN-VITRO SENSITIVITY TO FLUDARABINE AND 2-CHLORODEOXYADENOSINE IN B-CLL - AN ECOG STUDY, Blood, 88(10), 1996, pp. 2639-2639
Authors:
PAIETTA E
ANDERSEN J
RACEVSKIS J
ASHIGBI M
CASSILETH P
WIERNIK PH
Citation: E. Paietta et al., MODULATION OF MULTIDRUG-RESISTANCE IN DE-NOVO ADULT ACUTE MYELOID-LEUKEMIA - VARIABLE EFFICACY OF REVERTING AGENTS IN-VITRO, Blood reviews, 9(1), 1995, pp. 47-52
Authors:
TALLMAN M
HAKIMIAN D
WHEATON S
KOPECKY K
WOLLINS E
FOUCAR K
CASSILETH P
HABERMANN T
GREVER M
PETERSON LC
Citation: M. Tallman et al., MINIMAL RESIDUAL DISEASE IN PATIENTS WITH HAIRY-CELL LEUKEMIA IN COMPLETE REMISSION - COMPARISON OF 2-CHLORODEOXYADENOSINE WITH 2-DEOXYCOFORMYCIN AND PREDICTION OF EARLY RELAPSE, Blood, 86(10), 1995, pp. 1390-1390
Authors:
KITADA S
ANDERSEN J
HINES J
RAI K
CASSILETH P
REED JC
Citation: S. Kitada et al., EXPRESSION OF BCL-2 FAMILY GENES AND IN-VITRO SENSITIVITY TO FLUDARABINE AND 2-CHLORODEOXY-ADENOSINE IN B-CLL - AN ECOG STUDY, Blood, 86(10), 1995, pp. 2417-2417
Authors:
SCHENKEIN DP
MILLER KB
SWEET M
ROSENBACH M
STADTMAUER E
CASSILETH P
COOPER B
LAZARUS HM
Citation: Dp. Schenkein et al., A PHASE-II TRIAL OF FILGRASTIM (G-CSF) SUPPORTED HIGH-DOSE SEQUENTIALCHEMOTHERAPY AND PERIPHERAL BOOD STEM-CELL (PBSC) TRANSPLANTATION AS INITIAL THERAPY FOR HIGH-RISK NON-HODSKINS LYMPHOMA(NHL) - A MULTICENTER PILOT-STUDY, Blood, 86(10), 1995, pp. 3844-3844
Authors:
PAIETTA E
ANDERSEN J
RACEVSKIS J
BENNETT J
ROWE JM
CASSILETH P
WIERNIK PH
Citation: E. Paietta et al., MULTIDRUG-RESISTANCE GENE (MDR-1) TRANSCRIPT OR CD34 ANTIGEN EXPRESSION LEVELS DO NOT PREDICT FOR COMPLETE REMISSIONS IN DE-NOVO ADULT ACUTE MYELOID-LEUKEMIA (AML) - AN EASTERN-COOPERATIVE-ONCOLOGY-GROUP STUDY, Blood, 84(10), 1994, pp. 10000377-10000377
Authors:
HOCHSTER H
OKEN M
BENNETT J
WOLF B
GORDON L
RAPHAEL B
GENCARELLI P
CASSILETH P
Citation: H. Hochster et al., EFFICACY OF CYCLOPHOSPHAMIDE (CYC) AND FLUDARABINE (FAMP) AS 1ST LINETHERAPY OF LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL) - ECOG 1491, Blood, 84(10), 1994, pp. 10000383-10000383
Authors:
DUTCHER JP
LEONG T
MAKARY A
PAIETTA E
BENNETT J
CASSILETH P
WIERNIK PH
Citation: Jp. Dutcher et al., PHASE-II STUDY OF MENOGARIL IN PATIENTS (PTS) WITH RELAPSED REFRACTORY ACUTE MYELOID-LEUKEMIA (AML) - EST 8490, Blood, 82(10), 1993, pp. 10000130-10000130
Authors:
GREVER M
KOPECKY K
HEAD D
FOUCAR K
CASSILETH P
GOLOMB H
HABERMANN T
RAI K
EISENHAUER E
APPELBAUM F
CHESON B
Citation: M. Grever et al., A RANDOMIZED COMPARISON OF DEOXYCOFORMYCIN (DCF) VERSUS ALPHA-2A INTERFERON (IFN) IN PREVIOUSLY UNTREATED PATIENTS (PTS) WITH HAIRY-CELL LEUKEMIA (HCL) - AN UPDATED REPORT ON THE NCI-SPONSORED INTERGROUP STUDY(SWOG, ECOG, CALGB, NCIC CTG), Blood, 82(10), 1993, pp. 10000199-10000199